1. Home
  2. LXRX vs ODV Comparison

LXRX vs ODV Comparison

Compare LXRX & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ODV
  • Stock Information
  • Founded
  • LXRX 1995
  • ODV 2005
  • Country
  • LXRX United States
  • ODV Canada
  • Employees
  • LXRX 103
  • ODV N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ODV Precious Metals
  • Sector
  • LXRX Health Care
  • ODV Basic Materials
  • Exchange
  • LXRX Nasdaq
  • ODV Nasdaq
  • Market Cap
  • LXRX 388.6M
  • ODV 338.9M
  • IPO Year
  • LXRX 2000
  • ODV N/A
  • Fundamental
  • Price
  • LXRX $1.07
  • ODV $2.22
  • Analyst Decision
  • LXRX Buy
  • ODV
  • Analyst Count
  • LXRX 4
  • ODV 0
  • Target Price
  • LXRX $3.67
  • ODV N/A
  • AVG Volume (30 Days)
  • LXRX 3.5M
  • ODV 766.8K
  • Earning Date
  • LXRX 08-06-2025
  • ODV 08-11-2025
  • Dividend Yield
  • LXRX N/A
  • ODV N/A
  • EPS Growth
  • LXRX N/A
  • ODV N/A
  • EPS
  • LXRX N/A
  • ODV N/A
  • Revenue
  • LXRX $31,213,000.00
  • ODV $1,943,159.00
  • Revenue This Year
  • LXRX N/A
  • ODV $344.23
  • Revenue Next Year
  • LXRX N/A
  • ODV $70.34
  • P/E Ratio
  • LXRX N/A
  • ODV N/A
  • Revenue Growth
  • LXRX 1251.21
  • ODV N/A
  • 52 Week Low
  • LXRX $0.28
  • ODV $1.16
  • 52 Week High
  • LXRX $2.25
  • ODV $2.75
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 52.30
  • ODV 45.43
  • Support Level
  • LXRX $1.00
  • ODV $2.41
  • Resistance Level
  • LXRX $1.11
  • ODV $2.63
  • Average True Range (ATR)
  • LXRX 0.10
  • ODV 0.11
  • MACD
  • LXRX -0.03
  • ODV -0.05
  • Stochastic Oscillator
  • LXRX 16.28
  • ODV 14.36

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.

Share on Social Networks: